Diffuse alveolar hemorrhage: An evolving problem?

Leukemia

Volumn 17, Issue 6, 2003, Pages 1049-1050

  Weisdorf, D J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; HEMOSTATIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BRONCHOSCOPY; CLINICAL FEATURE; COUGHING; DRUG MEGADOSE; DYSPNEA; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; LEUKOCYTE COUNT; LUNG EDEMA; LUNG HEMORRHAGE; NEUTROPHIL; NOTE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RISK ASSESSMENT; RISK FACTOR; STEM CELL TRANSPLANTATION;

EID: 0037702921     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402921     Document Type: Note

References (14)

1. Gopal R, Ha CS, Tucker SL, Khouri IF, Giralt SA, Gajewski JL et al. Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity. Cancer 2001; 92: 1949-1958.
2. Worthy SA, Flint JD, Muller NL. Pulmonary complications after bone marrow transplantation: high- resolution CT and pathologic findings. Radiographics 1997; 17: 1359-1371.
3. Ho VT, Weller E, Lee SJ, Alyea EP, Antin JH, Soiffer RJ. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 223-229.
4. Crawford SW. Noninfectious lung disease in the immunocompromised host. Respiration 1999; 66: 385-395.
5. Robbins RA, Linder J, Stahl MG, Thompson III AB, Haire W, Kessinger A et al. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med 1989; 87: 511-518.
6. Specks U. Diffuse alveolar hemorrhage syndromes. Curr Opin Rheumatol 2001; 13: 12-17.
7. Nevo S, Vogelsang GB. Acute bleeding complications in patients after bone marrow transplantation. Curr Opin Hematol 2001; 8: 319-325.
8. Lewis ID, DeFor T, Weisdorf DJ. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy. Bone Marrow Transplant 2000; 26: 539-543.
9. Cohen S. Diffuse pulmonary hemorrhage: evolutionary 'flaw' or consequence of evolutionary progress? Am J Med Sci 2002; 323: 130-139.
10. Sisson JH, Thompson AB, Anderson JR, Robbins RA, Spurzem JR, Spence PR et al. Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin disease. Am Rev Respir Dis 1992; 146: 439-443.
11. Betensley AD, Yankaskas JR. Factor VIIA for alveolar hemorrhage in microscopic polyangiitis. Am J Respir Crit Care Med 2002; 166: 1291-1292.
12. Afessa B, Tefferi A, Litzow MR, Peters SG. Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002; 166: 1364-1368.
13. Heggen J, West C, Olson E, Olson T, Teague G, Fortenberry J et al. Diffuse alveolar hemorrhage in pediatric hematopoietic cell transplant patients. Pediatrics 2002; 109: 965-971.
14. Antin JH, Weisdorf D, Neuberg D, Nicklow R, Clouthier S, Lee SJ et al. Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation. Blood 2002; 100: 3479-3482.